Skip to content

BHIVA: Current tests may miss a third of HIV resistance in treatment-naive

Deal lowers price of second-line therapy and makes new paediatric formulations available to poorer countries

Africa: Epidemic outpacing response says UNAIDS

BHIVA: No evidence of a hepatitis C epidemic in HIV negative gay men

Clinical monitoring as effective as CD4 count and viral load for deciding when to switch to second-line ART in poor countries

Higher CD4 cell counts associated with lower rate of non-HIV-related diseases in patients taking antiretrovirals

Tenofovir shows excellent promise as a treatment for hepatitis B monoinfection

BHIVA: No clinical difference seen in first-line treatment response between B and non-B subtypes

Pharmacokinetics of paediatric Triomune fixed-dose formulations appear appropriate in African children